v3.26.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2024   96,048,999          
Beginning balance at Dec. 31, 2024 $ 552,619 $ 96 $ (118,542) $ 910,237 $ (275,786) $ (1,180) $ 37,794
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries 19,697       18,264   1,433
Other comprehensive income (loss) 1,411         1,411  
Stock options exercised (in shares)   8,333          
Stock options exercised 30     30      
Issuance of common stock for vesting of restricted stock units (in shares)   521,041          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   56,162          
Shares withheld related to net share settlement of share-based awards (in shares)   (174,157)          
Shares withheld related to net share settlement of share-based awards (670)     (670)      
Compensation expense for share-based awards 3,751     3,751      
Ending balance (in shares) at Sep. 30, 2025   96,460,378          
Ending balance at Sep. 30, 2025 576,838 $ 96 (118,542) 913,348 (257,522) 231 39,227
Beginning balance (in shares) at Jun. 30, 2025   96,444,993          
Beginning balance at Jun. 30, 2025 577,471 $ 96 (118,542) 911,473 (254,792) 345 38,891
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries (2,394)       (2,730)   336
Other comprehensive income (loss) (114)         (114)  
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   15,385          
Compensation expense for share-based awards 1,875     1,875      
Ending balance (in shares) at Sep. 30, 2025   96,460,378          
Ending balance at Sep. 30, 2025 576,838 $ 96 (118,542) 913,348 (257,522) 231 39,227
Beginning balance (in shares) at Dec. 31, 2025   96,475,469          
Beginning balance at Dec. 31, 2025 584,032 $ 96 (118,542) 915,330 (254,104) 670 40,582
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries (31,955)       (21,255)   (10,700)
Other comprehensive income (loss) 239         239  
Issuance of common stock for vesting of restricted stock units (in shares)   1,758,841          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   27,969          
Shares withheld related to net share settlement of share-based awards (in shares)   (668,513)          
Shares withheld related to net share settlement of share-based awards (3,096) $ (1)   (3,095)      
Compensation expense for share-based awards 2,367     2,367      
Ending balance (in shares) at Sep. 30, 2026   97,593,766          
Ending balance at Sep. 30, 2026 551,589 $ 97 (118,542) 914,602 (275,359) 909 29,882
Beginning balance (in shares) at Jun. 30, 2026   97,586,805          
Beginning balance at Jun. 30, 2026 557,021 $ 97 (118,542) 914,451 (269,798) 580 30,233
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries (5,912)       (5,561)   (351)
Other comprehensive income (loss) 329         329  
Issuance of common stock for vesting of restricted stock units and performance based stock awards 2 $ 2          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   6,961          
Compensation expense for share-based awards 151     151      
Ending balance (in shares) at Sep. 30, 2026   97,593,766          
Ending balance at Sep. 30, 2026 $ 551,589 $ 97 $ (118,542) $ 914,602 $ (275,359) $ 909 $ 29,882